GLP1-Sema (10mg)
GLP-1S designates a long-acting GLP-1 receptor agonist research compound investigated for its kinetics and effects on glucose handling, insulin response, and appetite signaling.
About GLP-1S
GLP-1S designates a long-acting research compound targeting the GLP-1 receptor pathway, associated with extensive clinical and preclinical literature on weekly-dosing GLP-1 agonism.
Mechanism in Research Literature
As a GLP-1 receptor agonist, the compound has been documented to:
- Activate GLP-1 receptors in pancreatic, gastric, and central nervous system tissues
- Stimulate glucose-dependent insulin secretion
- Suppress glucagon release in a glucose-dependent manner
- Slow gastric emptying
- Affect appetite-regulating neural circuits
Research Context
GLP-1S-class compounds have been investigated in studies exploring:
- Long-acting GLP-1 receptor pharmacology
- Glucose homeostasis in type-2 diabetes research models
- Body weight and adipose tissue effects
- Cardiovascular outcomes literature
- Comparative pharmacokinetics vs. short- and intermediate-acting agonists
Related Research Peptides
GLP-1S appears in literature alongside GLP-1R (general receptor research) and GLP-1T (dual-receptor agonists), as well as related metabolic compounds (AOD-9604, Tesamorelin, 5-Amino-1MQ).
